Corrigendum: Carcinoma-Astrocyte gap junctions promote brain metastasis by cGAMP transfer (Nature 533 (2016) (493-498) DOI: 10.1038/nature18268);Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer

Nature

Volumn 533, Issue 7604, 2016, Pages 493-498

  Chen, Qing ^a,b   Boire, Adrienne ^a   Jin, Xin ^a,c   Valiente, Manuel ^a,d   Er, Ekrem Emrah ^a   Lopez Soto, Alejandro ^a,e   Jacob, Leni S ^a,f   Patwa, Ruzeen ^a   Shah, Hardik ^a   Xu, Ke ^a   Cross, Justin R ^a   Massague, Joan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WISTAR INSTITUTE   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e UNIVERSITY OF OVIEDO   (Spain)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CADHERIN; CARBOPLATIN; CONNEXIN 43; CYCLIC AMP DERIVATIVE; CYCLIC GMP AMP; CYCLIC GMP DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MECLOFENAMATE SODIUM; PACLITAXEL; PROTOCADHERIN 7; STAT1 PROTEIN; TONABERSAT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; BENZOPYRAN DERIVATIVE; CYCLIC GUANOSINE MONOPHOSPHATE-ADENOSINE MONOPHOSPHATE; CYCLIC NUCLEOTIDE; MECLOFENAMIC ACID; MEMBRANE PROTEIN; MPYS PROTEIN, HUMAN; MPYS PROTEIN, MOUSE; PCDH7 PROTEIN, HUMAN; PCDH7 PROTEIN, MOUSE;

BRAIN; CANCER; CELLS AND CELL COMPONENTS; CHEMOTHERAPY; DISEASE TREATMENT; MORBIDITY; MORTALITY; RODENT; TUMOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG BIOAVAILABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAP JUNCTION; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG CANCER; MICROGLIA; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RNA SEQUENCE; SECOND MESSENGER; TUMOR GROWTH; ANIMAL; BRAIN NEOPLASMS; BREAST TUMOR; COCULTURE; CYTOLOGY; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; INNATE IMMUNITY; LUNG TUMOR; METABOLISM; PATHOLOGY; SECONDARY; SECRETION (PROCESS); TUMOR CELL LINE;

ANIMALS; ASTROCYTES; BENZAMIDES; BENZOPYRANS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CONNEXIN 43; DRUG RESISTANCE, NEOPLASM; FEMALE; GAP JUNCTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON-ALPHA; LUNG NEOPLASMS; MECLOFENAMIC ACID; MEMBRANE PROTEINS; MICE; NF-KAPPA B; NUCLEOTIDES, CYCLIC; PARACRINE COMMUNICATION; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84971237993     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature21730     Document Type: Erratum

References (51)

1. Gavrilovic, I. T., Posner, J. B. Brain metastases: epidemiology and pathophysiology. J. Neurooncol. 75, 5-14 (2005).
2. Stelzer, K. J. Epidemiology and prognosis of brain metastases. Surg. Neurol. Int. 4, S192-S202 (2013).
3. Bos, P. D. et al. Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005-1009 (2009).
4. Eichler, A. F. et al. The biology of brain metastases-translation to new therapies. Nature Rev. Clin. Oncol. 8, 344-356 (2011).
5. Kienast, Y. et al. Real-time imaging reveals the single steps of brain metastasis formation. Nature Med. 16, 116-122 (2010).
6. Valiente, M. et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 156, 1002-1016 (2014).
7. Giaume, C., Koulakoff, A., Roux, L., Holcman, D., Rouach, N. Astroglial networks: a step further in neuroglial and gliovascular interactions. Nature Rev. Neurosci. 11, 87-99 (2010).
8. Sofroniew, M. V., Vinters, H. V. Astrocytes: biology and pathology. Acta Neuropathol. 119, 7-35 (2010).
9. Kim, S. J. et al. Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia 13, 286-298 (2011).
10. Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826-830 (2013).
11. Theis, M., Giaume, C. Connexin-based intercellular communication and astrocyte heterogeneity. Brain Res. 1487, 88-98 (2012).
12. Nguyen, D. X. et al. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138, 51-62 (2009).
13. Winslow, M. M. et al. Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 473, 101-104 (2011).
14. Oshima, A. Structure and closure of connexin gap junction channels. FEBS Lett. 588, 1230-1237 (2014).
15. Yoshida, K., Yoshitomo-Nakagawa, K., Seki, N., Sasaki, M., Sugano, S. Cloning, expression analysis, and chromosomal localization of BH-protocadherin (PCDH7), a novel member of the cadherin superfamily. Genomics 49, 458-461 (1998).
16. Kim, S. Y., Chung, H. S., Sun, W., Kim, H. Spatiotemporal expression pattern of non-clustered protocadherin family members in the developing rat brain. Neuroscience 147, 996-1021 (2007).
17. Gaspar, L. E. et al. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. J. Clin. Oncol. 23, 2955-2961 (2005).
18. Gaspar, L. E., Scott, C., Murray, K., Curran, W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 47, 1001-1006 (2000).
19. Yagi, T., Takeichi, M. Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev. 14, 1169-1180 (2000).
20. Osswald, M. et al. Brain tumour cells interconnect to a functional and resistant network. Nature 528, 93-98 (2015).
21. Sin, W. C. et al. Astrocytes promote glioma invasion via the gap junction protein connexin43. Oncogene 35, 1504-1516 (2015).
22. Luker, K. E. et al. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc. Natl Acad. Sci. USA 101, 12288-12293 (2004).
23. Beahm, D. L. et al. Mutation of a conserved threonine in the third transmembrane helix of ?-and ?-connexins creates a dominant-negative closed gap junction channel. J. Biol. Chem. 281, 7994-8009 (2006).
24. Heiman, M. et al. A translational profiling approach for the molecular characterization of CNS cell types. Cell 135, 738-748 (2008).
25. Boehm, J. S. et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129, 1065-1079 (2007).
26. Cai, X., Chiu, Y. H., Chen, Z. J. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol. Cell 54, 289-296 (2014).
27. Stetson, D. B., Medzhitov, R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24, 93-103 (2006).
28. Harks, E. G. et al. Fenamates: a novel class of reversible gap junction blockers. J. Pharmacol. Exp. Ther. 298, 1033-1041 (2001).
29. Jin, M. et al. Effects of meclofenamic acid on limbic epileptogenesis in mice kindling models. Neurosci. Lett. 543, 110-114 (2013).
30. Chan, W. N. et al. Identification of (?)-cis-6-acetyl-4S-(3-chloro-4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent. Bioorg. Med. Chem. Lett. 9, 285-290 (1999).
31. Herdon, H. J. et al. Characterization of the binding of [3H]-SB-204269, a radiolabelled form of the new anticonvulsant SB-204269, to a novel binding site in rat brain membranes. Br. J. Pharmacol. 121, 1687-1691 (1997).
32. Read, S. J., Smith, M. I., Hunter, A. J., Upton, N., Parsons, A. A. SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat. Cephalalgia 20, 92-99 (2000).
33. Damodaram, S., Thalakoti, S., Freeman, S. E., Garrett, F. G., Durham, P. L. Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. Headache 49, 5-20 (2009).
34. Deeken, J. F., Loscher, W. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clin. Cancer Res. 13, 1663-1674 (2007).
35. Pitz, M. W., Desai, A., Grossman, S. A., Blakeley, J. O. Tissue concentration of systemically administered antineoplastic agents in human brain tumors. J. Neurooncol. 104, 629-638 (2011).
36. Lim, E., Lin, N. U. Updates on the management of breast cancer brain metastases. Oncology 28, 572-578 (2014).
37. Taimur, S., Edelman, M. J. Treatment options for brain metastases in patients with non-small-cell lung cancer. Curr. Oncol. Rep. 5, 342-346 (2003).
38. Hirano, S., Suzuki, S. T., Redies, C. The cadherin superfamily in neural development: diversity, function and interaction with other molecules. Front. Biosci. 8, d306-d355 (2003).
39. Patel, S. J., King, K. R., Casali, M., Yarmush, M. L. DNA-triggered innate immune responses are propagated by gap junction communication. Proc. Natl Acad. Sci. USA 106, 12867-12872 (2009).
40. Ablasser, A. et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 503, 530-534 (2013).
41. Demaria, O. et al. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proc. Natl Acad. Sci. USA 112, 15408-15413 (2015).
42. Woo, S. R. et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41, 830-842 (2014).
43. Sauer, J. D. et al. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79, 688-694 (2011).
44. Zhang, X. H. et al. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell 154, 1060-1073 (2013).
45. Wilson, A. A. et al. Lentiviral delivery of RNAi for in vivo lineage-specific modulation of gene expression in mouse lung macrophages. Mol. Ther. 21, 825-833 (2013).
46. Anders, S. et al. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nature Protocols 8, 1765-1786 (2013).
47. Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
48. Love, M. I., Huber, W., Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
49. Gatza, M. L. et al. A pathway-based classification of human breast cancer. Proc. Natl Acad. Sci. USA 107, 6994-6999 (2010).
50. Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524 (2005).
51. Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549 (2003).